| Application no. and date | 06787733.2 (espacenet) (Federated) (European Patent Register), 20060718 | | Patent/reg. no. and date | DK/EP 1910336, 20110629 | | Publication date | 20080416 | | Priority no. and date | US 701406 P, 20050720, US 716213 P, 20050912 | | EP pub. no. and date |
EP 1910336 20080416 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 142165 | | Inventor | SHIEH, Wen-Chung, 295 Timber Drive
Berkeley Heights, NJ 07922, US,
SUTTON, Paul, Allen, 34 Irvington Road
Parsippany, NJ 07054, US,
MANLEY, Paul, W., Bruggweg 12
CH-4144 Arlesheim, CH,
KARPINSKI, Piotr, H., 25 Terrace Parkway
Lincoln Park, NJ 07035, US,
MONNIER, Stéphanie, 6 Le Parc
F-68190 Raedersheim, FR,
WU, Raeann, 2423 Rachel Terrace
Pine Brook, NJ 07058, US,
BROZIO, Jörg, Spalentorweg 20
CH-4051 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/14 (2006.01) | | Title | 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluormethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamid-monohydrochloridsalt-monohydrat | | Int. application no. | US2006027878 | | Int. publication no. | WO2007015871 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
